The results showed that blockade of glutamine uptake using V9302[32] combined mTORC1/2 inhibitor AZD2014 blocking the interaction between HDAC3 and GS (Figure S7E, Supporting Information) not only significantly delayed the tumor growth but also resulted in partial or even complete tumor regression (Figure S8A–D, Supporting Information). Here, GLUL is linked to neoplasm.